Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder
about
A Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline PharmacotherapyThe potential impact on farmer health of enhanced export horticultural trade between the U.K. and Uganda.Health-related quality of life among general practice patients with differing chronic diseases in Germany: cross sectional survey.Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana.Serious child and adolescent behaviour disorders; a valuation study by professionals, youth and parents.Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disordersThe impact of decision aids to enhance shared decision making for diabetes (the DAD study): protocol of a cluster randomized trial.Innovation in health economic modelling of service improvements for longer-term depression: demonstration in a local health communityImportance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional studyQuality of Life in Depressed Patients in UK Primary Care: The FINDER Study.Design of Economic Evaluations of Mindfulness-Based Interventions: Ten Methodological Questions of Which to Be Mindful.Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting.Health state utilities associated with attributes of treatments for hepatitis C.EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD).Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: An Economic Analysis.Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients.Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?A review of antidepressant therapy in primary care: current practices and future directions.Health-related quality of life in older depressed psychogeriatric patients: one year follow-upQuality of life and use of health care resources among patients with chronic depressionThe impact of residual symptoms on relapse and quality of life among Thai depressive patients.Utility Values for Adults with Unipolar Depression: Systematic Review and Meta-Analysis.The Clinical and Cost Effectiveness of Vortioxetine for the Treatment of a Major Depressive Episode in Patients With Failed Prior Antidepressant Therapy: A Critique of the Evidence.Quality of life in older individuals with joint contractures in geriatric care settings.Moving evidence-based interventions to populations: a case study using social workers in primary care.Associations between living arrangements and health-related quality of life of urban elderly people: a study from China.Factors associated with and impact of pain persistence in Asian patients with depression: a 3-month, prospective observational study.Depression screening with patient-targeted feedback in cardiology: The cost-effectiveness of DEPSCREEN-INFO.Chinese patients with major depression: Do concomitant pain symptoms affect quality of life independently of severity of depression?Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice.Usefulness of EQ-5D for evaluation of health-related quality of life in young adults with first-episode psychosis.Evidence on the longitudinal construct validity of major generic and utility measures of health-related quality of life in teens with depression.Cost-effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial.Impact of painful physical symptoms on depression outcomes in elderly Asian patients.A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders.Health-related quality of life in patients with Gilles de la Tourette's syndrome.Characteristics of patients with depression initiating or switching antidepressant treatment: baseline analyses of the PERFORM cohort study.Treatment of acromegaly improves quality of life, measured by AcroQol.Identifying and assessing the benefits of interventions for postnatal depression: a systematic review of economic evaluations.The Impact of Chronic Discogenic Low Back Pain: Costs and Patients' Burden
P2860
Q28468503-6C448522-EB06-468A-9ECB-847BAABD2EB4Q30397378-298F34C4-6E48-4C56-8F43-3A4025D4CB1BQ33353077-3AC54F16-F53F-4CCB-9D61-1D308BE53903Q33751459-ED8427AA-101A-4940-9478-E7E2BE3B3CFDQ33759324-792496E0-C4C3-4082-940A-C4607716FA67Q33864811-4AADF199-1284-49FA-A937-9859604E9B2EQ34284476-F2D5BD66-0E93-4BC3-82C3-12680360ED1AQ34691029-9C464F11-FE80-4FCD-A446-BBD198341C48Q34789393-A513344D-1F18-4681-924F-33208AE5505EQ35309316-101561EA-4AEC-4DD9-943C-5B42537F0A75Q35607322-CF2C2132-D9A9-48BA-93BF-9D348B54683DQ36208461-24F25485-553D-47B1-ADEB-7EFE6E44BF02Q36285092-11E1727B-7DEF-4BF0-BB03-4EDF83AFDE40Q36494300-25189BD6-053C-4B27-A187-E1C6ABFA7C47Q36731642-52949039-D8AD-413A-B99B-A5C14BD31F34Q36802781-F570479F-4A5D-472A-9EA1-5B36003B1812Q36957237-617AB308-2DB1-4D7A-9448-506F96A8D19CQ37070398-19727F6C-9305-4498-9CCF-BBCA0A4FDE0DQ37073707-03E5B551-4E26-4223-9CB0-1994699A681FQ37301359-C40CF2A5-5640-48DD-9A54-A79E444141E9Q37510121-ECD31125-E279-46F0-BC9C-1CE8F0599B67Q38201656-2192370F-8F38-4903-9931-433B36D61094Q38862355-669E4B30-5891-496C-86AF-1953BFE8653DQ38894768-E0AEF761-3349-4580-93CF-CA044DD84B3AQ39760399-C4EA43D2-EB14-4084-8F28-2CF2F2AAFB0EQ39833123-7C6AA973-731C-452D-9067-BFECC2031A14Q40515464-C5E7CF09-160D-4121-9DB2-93F5B5E1BB1DQ41383713-ABED364E-8144-4418-8726-E026B7BADCE1Q41757841-5E2B197D-9A99-497F-9936-EF9904C79202Q44030189-31BBBFBC-6705-467E-9C44-00C8FD6584C3Q47611486-DA012246-71BB-4A4C-A261-6AC4D9C9F051Q47705624-9AF3C79B-8676-4EA4-89D4-941E6D897260Q48031262-D03231EC-83A6-4EAA-8D41-C86DC9379D74Q48181643-78EB25B7-53A3-4C37-BE31-62FB1BC54863Q48868283-BC8811F6-FD09-4813-AD3C-3A80BA4F3240Q48912571-8EA1B5C6-4C5A-40ED-B118-00F5AA856C45Q52627342-E02C7631-15F0-4202-85E2-398C642E59F6Q53189116-BE340E11-215A-4467-B677-8DDF311900A7Q55383975-239ECC94-B735-4BE0-A800-133538FBDF57Q58599488-D1DFD72D-C050-477A-AFD1-91CF362AE895
P2860
Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Usefulness of EQ-5D in assessi ...... with major depressive disorder
@ast
Usefulness of EQ-5D in assessi ...... with major depressive disorder
@en
Usefulness of EQ-5D in assessi ...... with major depressive disorder
@nl
type
label
Usefulness of EQ-5D in assessi ...... with major depressive disorder
@ast
Usefulness of EQ-5D in assessi ...... with major depressive disorder
@en
Usefulness of EQ-5D in assessi ...... with major depressive disorder
@nl
prefLabel
Usefulness of EQ-5D in assessi ...... with major depressive disorder
@ast
Usefulness of EQ-5D in assessi ...... with major depressive disorder
@en
Usefulness of EQ-5D in assessi ...... with major depressive disorder
@nl
P2093
P2860
P3181
P356
P1476
Usefulness of EQ-5D in assessi ...... with major depressive disorder
@en
P2093
Bruno Fantino
Christophe Sapin
Marie-Laure Nowicki
P2860
P2888
P3181
P356
10.1186/1477-7525-2-20
P407
P50
P577
2004-05-05T00:00:00Z
P5875
P6179
1041533909